All News

Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio

HILLSBORO, OREGON (PRWEB) MARCH 13, 2020 Acumed LLC today announced that it has entered into an agreement with Vivorte Inc. to be the exclusive distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, Acumed will employ its sales, marketing, and medical education expertise to distribute Vivorte’s calcium phosphate-based bone allograft (Trabexus) and …

Global medical devices industry M&A deals total $413.18m in January 2020

Total medical devices industry M&A deals in January 2020 worth $413.18m were announced globally, according to GlobalData’s deals database. The value marked a decrease of 84.7% over the previous month and a drop of 87.7% when compared with the last 12-month average, which stood at $3.37bn. Comparing deals value in different regions of the globe, …

Additive Implants Achieves Milestone of 200 Levels Treated

PHOENIX, March 12, 2020 /PRNewswire/ — Additive Implants announced today that the company has reached the milestone of 200 spinal levels treated with the SureMAX™ Cervical Spacer. The milestone procedure was performed by Dr. Rafath Baig at Banner Desert Medical Center in Phoenix, Arizona. Dr. Baig commented: “I have been very pleased with the performance of the spacer and its unique surface …

CoNextions Inc. Announces FDA 510(k) Clearance of Coronet™ System, a Revolutionary Tenodesis Product

SALT LAKE CITY, March 12, 2020 /PRNewswire/ — CoNextions Inc. (www.conextionsmed.com) announced today that it received a 510(k) clearance (K200028) from the U.S. Food and Drug Administration (FDA) for CoronetTM System, a tenodesis product intended for the fixation of tissue to bone and tissue to tissue. The Coronet’s novel design improves the soft tissue fixation strength of these …

Ortho Regenerative Technologies Announces Positive Results from Pivotal Preclinical Study in Rotator Cuff Tear Repair

Safety profile of ORTHO-R confirmed.Statistical significance over standard of care demonstrated.ORTHO-R program advancing towards clinical phase. MONTREAL, March 12, 2020 /CNW/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company, today announced positive results following completion of its pivotal preclinical study in Rotator Cuff Tear repair. The results confirmed the safety …

InVivo Therapeutics Announces Closing of $7.0 Million Public Offering

March 11, 2020 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its previously announced public offering of 2,545,455 shares of common stock (or pre-funded warrants to purchase common stock in lieu thereof), together with warrants to purchase up to 2,545,455 shares of common stock at a combined effective price to the …

Bone Therapeutics announces 2019 full year results

Gosselies, Belgium, 11 March 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces its business update and full year financial results for the year ending 31 December 2019, prepared in accordance with IFRS as adopted by the …

APLIX Announces New inter-mold® Hooks for Medical and Orthopedic Applications

March 10, 2020 CHARLOTTE, N.C.–(BUSINESS WIRE)–APLIX today announced the commercialization of new inter-mold® low profile hooks for medical and orthopedic applications. The inter-mold® technology is a breakthrough patented one-step injection molding solution which allows the creation of hooks directly into plastic parts. This process streamlines and optimizes manufacturing practices by eliminating material and associated labor costs of attaching hook …

Positive results from follow-up of 30 patients in a Swedish multicentre clinical trial of the Episealer® Knee implant

Episurf Medical (Nasdaq: EPIS B) March 8, 2020 – Today announces that results from a clinical study with follow-up of the 30 first patients from nine Swedish clinics show good implant safety and significantly improved patient-reported outcome scores. Follow-ups of the patients are now completed, and the principle investigator will compile the results for submission …

Clinical Study Shows Improved Clinical Outcomes, High Rate of Return to Activity for Patients with Arthrosurface OVO® with Inlay Glenoid Shoulder Arthroplasty System

FRANKLIN, Mass., March 10, 2020 /PRNewswire/ — A new study published in the Journal of Shoulder and Elbow Surgery found that younger, active adults who underwent anatomic total shoulder arthroplasty (TSA) and received the OVO® with Inlay Glenoid Shoulder Arthroplasty System experienced excellent range of motion, improved clinical outcomes, no reoperations or radiographic loosening and a high rate of return …

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1